Two doses of the AstraZeneca vaccine were 60 per cent effective against symptomatic disease from the India variant compared with 66 per cent effectiveness against the Kent variant. Source

JOIN NCOV.LINK NEWSLETTER

And get notified everytime we publish a new Important announcements. We will not email you often, unless there are important things that need to get in touch with you, such as added new tools or new domain names.